Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After …
[ad_1]
Excited to present on #suprachoroidal drug delivery at
@OphthalmologyFF! After FDA approval of #Xipere, SC delivery became a reality. Now, #clinicaltrials involving SC delivery include a TKI, a steroid, a #genetherapy & a virus-like drug conjugate. #eyes
https://t.co/SyafhDOM7l https://t.co/J7G54DeoOw
[ad_2]
Source by Thomas Ciulla, MD, MBA